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ABSTRACT
Mammalian mitochondria contain full-length
genome and a single-stranded 7S DNA. Although
the copy number of mitochondrial DNA (mtDNA)
varies depending on the cell type and also in
response to diverse environmental stresses, our
understanding of how mtDNA and 7S DNA are main-
tained and regulated is limited, partly due to lack of
reliable in vitro assay systems that reflect the in vivo
functionality of mitochondria. Here we report an
in vitro assay system to measure synthesis of both
mtDNA and 7S DNA under a controllable in vitro
condition. With this assay system, we demonstrate
that the replication capacity of mitochondria correl-
ates with endogenous copy numbers of mtDNA and
7S DNA. Our study also shows that higher nucleo-
tide concentrations increasingly promote 7S DNA
synthesis but not mtDNA synthesis. Consistently,
the mitochondrial capacity to synthesize 7S DNA
but not mtDNA noticeably varied along the cell
cycle, reaching its highest level in S phase. These
findings suggest that syntheses of mtDNA and
7S DNA proceed independently and that the
mitochondrial capacity to synthesize 7S DNA dy-
namically changes not only with cell-cycle progres-
sion but also in response to varying nucleotide
concentrations.
INTRODUCTION
Most animal cells contain two sets of genetic information,
one in the nucleus and the other in mitochondria.
Although human mitochondria harbor a relatively small
genome of only 16569bp (1), a high incidence of diverse
metabolic diseases and various cancers are associated with
alterations in the mitochondrial genome (2–4), clearly
indicating the signiﬁcance of its stable maintenance.
Mammals typically contain  10
3–10
4 copies of mitochon-
drial DNA (mtDNA) per cell (5–7). Early studies, using
electron microscopy, indicated that mammalian mtDNA
contains an unwound or displaced single-stranded region,
called the D-loop (8,9). The 50-end of the D-loop region
coincides with the replication origin of the H-strand (OH),
while the 30-end contains the termination-associated
sequence (TAS) (10). Replication of mammalian
mtDNA initiates at the OH and frequently terminates at
the TAS site, generating a short single-stranded DNA
(ssDNA) fragment, called 7S DNA (9,10).
Several studies have reported in vitro synthesis of
mtDNA and 7S DNA in isolated mitochondria, through
which a rapid turnover of 7S DNA as well as direct uptake
of dNTP by mitochondria and subsequent utilization for
mtDNA synthesis have been demonstrated (11–15). Also,
Mitra and Bernstein (14) proposed for the ﬁrst time the
conversion of thymidine to TTP within mitochondria (i.e.
the presence of the mitochondrial nucleotide salvage
pathway). These previous studies testify to the potential
of an in vitro assay system to gain insights into the mech-
anism of mtDNA replication. However, whether mtDNA
synthesis measured in vitro is catalyzed by mitochondrial
DNA polymerase g, reﬂecting the in vivo replication
capacity of mitochondria, and whether in vitro assay
systems are suitable to study the regulation of mtDNA
copy number remain unexplored.
Recently, while establishing an in vitro assay system for
human DNA replication, we observed de novo DNA
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ous DNA template. Subsequent analysis revealed that the
de novo synthesized DNA is the human full-length mito-
chondrial genome. In this report, we describe that
mtDNA synthesis measured in vitro is resistant to
aphidicolin but sensitive to dideoxynucleotide, indicating
that mitochondria-speciﬁc DNA polymerase g is respon-
sible for the observed mtDNA synthesis. Using this assay
system, we observed that the capacity of mitochondria to
synthesize 7S DNA but not mtDNA changes with
cell-cycle progression and with varying nucleotide concen-
trations. Thus we conclude that syntheses of 7S DNA syn-
thesis and mtDNA occur independently of each other.
MATERIALS AND METHODS
Preparation of replication–competent cytoplasmic and
nuclear extracts
HeLa cells were grown in 5–20, 150mm culture plates to
 80% conﬂuence. On the day of harvesting, cells were
replenished with fresh media and  6h later were collected
in conical tubes. After washing with ice-cold PBS, cells
were treated with a hypotonic buﬀer [10mM HEPES–
HCl, pH 7.4, 1.5mM MgCl2, 10mM KCl, 0.5mM
dithiothreitol (DTT) and 5mM b-glycerophosphate] on
ice for 15min and homogenized with 10 stokes using a
type B pestle (Kontes). Homogenates were cleared by cen-
trifugation for 15min at 2000g, and the nuclear pellet was
salt-extracted as described previously (16). The resultant
nuclear extracts (NEs) were dialyzed against buﬀer G,
consisting of 20mM Hepes–HCl, pH 7.4, 0.1M NaCl,
0.5mM DTT, 0.2mM ethylenediamine tetra-acetate,
5mMb-glycerophosphate and 20% glycerol, and cleared
by centrifugation at 25000g for 30min (N1) or 100000g
for 1h (N2). On the other hand, the homogenate super-
natants were dialyzed for 4h against buﬀer G lacking
b-glycerophosphate (buﬀer A) and the dialysates (C4)
were stored at  70 C in aliquots. The dialysates were
further subjected to centrifugation at 100000g for 1h
(C1), 25000g (C2) or 10000g for 15min (C3) and the
clear supernantants were stored at  70 C in aliquots.
Throughout the presented study for mtDNA replication
and 7S DNA synthesis in vitro, replication–competent
cytoplasmic extracts (CEs) were prepared the same as C4.
Cell synchronization
HeLa cells were seeded to 10% conﬂuence in three groups
(A–C) on 100-mm culture plates for determination of en-
dogenous levels of mtDNA and 7S DNA or in three
groups of ten 150-mm culture plates for the preparation
of replication competent CE. On the following day, cells
were replenished with fresh DME medium containing
2mM thymidine and 7% fetal bovine serum (FBS).
After 16h-incubation, culture plates were washed twice
with serum-free DME, then supplemented with 24mM
deoxycytidine and 7% FBS. After incubation for 9h at
37 C, cells were washed twice, provided with DME con-
taining 2mM thymidine and 7% FBS, and then continu-
ously incubated for 20h. Cells in group A were harvested
immediately but cells in group B were incubated for an
additional 7h in DME containing 7% FBS and those
in group C were grown for 18h in DME containing 7%
FBS and 0.2mM nocodazole (Sigma). Cells were collected
using policeman and washed twice with ice-cold 1  PBS.
Cells obtained from 100mm culture plates were split into
two 15ml conical tubes. Cells in one tube were
re-suspended in buﬀer G (0.5ml) and stored at  70 Ci n
aliquots. Cells in another tube were stained with
propidium iodide (Invitrogen) and subjected to standard
ﬂuorescence activated cell sorter (FACS) analysis (BD
Biosciences FACSCaliburs) to determine the extent of
their synchrony at a speciﬁc stage of the cell cycle. On
the other hand, cells harvested from 150mm plates were
processed to prepare the replication–competent CE, as
described earlier.
Western blot analysis
Aliquots of cytoplasmic fractions enriched in
mitochondria and other subcellular fractions, indicated
in Figure 3, were mixed with one-ﬁfth volume of
5  sodium dodecylsulfate (SDS) sample buﬀer and
heated at 95 C for 5min. Subsequently, they were
separated by 10% SDS–PAGE and proteins were
transferred to PVDF ﬁlter (Schleicher and Schuell) using
the SemiDry system (Bio-Rad). Western blot analysis was
performed using an ECL reagent (Amersham Biosciences)
and indicated antibodies (Ab) including, mouse anti-
topoisomerase IIa Ab (1:1000 dilution) (BD
Biosciences), mouse anti-a-tubulin Ab (1:2000 dilution)
(Santa Cruz) and rabbit anti-mtSSB Ab (1:300 dilution)
(a kind gift of Dr M. Zeviani).
In vitro mtDNA synthesis
Unless otherwise indicated, the reaction mixture (20ml)
contained 30mM Tris–HCl, pH 8.5, 0.1M potassium
acetate, 7mM MgCl2, 0.5mM dithiothreitol (DTT),
4mM ATP, 0.2mM CTP/UTP/GTP, 0.1mM dCTP/
dTTP/dGTP, 20mM dATP/2mCi a-
32P-dATP
(3000Ci/mmol), 6mM creatine phosphate (CP), 1.25mg
of creatine phosphokinase (CPK), 0.1mg/ml bovine
serum albumin and  50mg of CE. In Figure 1, however,
the reaction mixture was constituted with 100mgo fC Ei n
a ﬁnal volume of 50ml. After incubation at 37 C for 2h,
the reaction mixture was centrifuged at 10000g for 1min
four times, while washing with buﬀer G ( 2ml). The ﬁnal
pellet, enriched in mitochondria, was re-suspended in a
mixture (12ml) of SDS (0.5%) and proteinase K
(0.25mg/ml). Subsequent to incubation at 37 C for an
additional 1h, the lysate was mixed with 3mlo f5   gel
loading buﬀer (50% glycerol, 0.1% xylene cyanol and
0.1% bromophenol blue) and resolved on a 1% agarose
gel in 1  TAE buﬀer using a 1-kb ladder (Invitrogen) as a
molecular standard. The gel was electrophoresed at
constant 80V for 2.5h, washed with deionized water,
and dried under vacuum on Whatman DE-81 paper.
De novo synthesized DNA was visualized by autoradiog-
raphy and quantiﬁed using a PhosphorImager (Molecular
Dynamics).
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For experiments in Figure 4, the LightCycler (Roche) was
used to measure copy number of full-length mtDNA,
7S DNA and b-actin DNA. Forward primer a,
50-gtggctttggagttgcagtt-30, is derived from nucleotide
position 16240–16259 within the D-loop of mtDNA
sequence. Sequences of reverse primers b1 and b2 are
50-cagccaccatgaatattgtac-30 and 50-gaagcagatttgggtaccac-30
that map to positions 16108–16128 and 16036–16055,
respectively. Forward and reverse primers for b-actin
DNA are derived from nucleotide positions 1315–1337
(50-agaaaaatctggcaccacaccttc-30) and 1547–1570 (50-gcaga
gttccaaaggagactcagg-30) (Genbank CCDS 5341.1). Each
reaction was provided with 1  LightCycler FastStart
DNA Master HybProbe, 300nM each of the forward
and reverse primer, 200nM probe and 0.1 unit heat-labile
uracil-DNA glycosylase (Roche) in a total volume of 10ml.
In each run, pKW125 (17), a plasmid DNA containing
amplicon representing full-length mtDNA, was run as
an external control. The probe for the ensuing amplicon
is located at nucleotide position 13461–13480 and is
tagged with the reporter FAM (6-carboxy ﬂuorescein,
 max 518nm) at the 50 end and the quencher BHQ1 at
the 30 end. The copy numbers of mtDNA and 7S DNA
per cell was determined from the plasmid control copy
number and its threshold cycle following the procedure
previously described (17). For experiments in Figure 5,
RT–qPCR was carried out using Applied Biosystem
7500 system in a mixture (20ml) containing  500–1000
(reaction for mtDNA or 7S DNA) or  10000 HeLa
cells (reaction for b-actin DNA), 1  SYBR Green
Master Mix and each of the forward and reverse primers
(200nM).
Figure 1. Analysis of de novo synthesized DNA. (A) Control replication reactions were carried out in the standard reaction mixture (50ml), as
described in ‘Materials and Methods’ section, with either 100mg of cytoplasmic extract (C1–C4) (lanes 1–4, respectively) or 50mg of nuclear extract
(N1 & N2) (lanes 5 and 6), but omitting the template DNA, pSLVD (Supplementary Figure S1). Procedures employed for the preparation of C1-4
and N1-2 are detailed in ‘Material and Methods’ section. DNA, isolated by conventional phenol/chloroform extraction and ethanol precipitation,
was resolved on a 1% agarose gel. Subsequently, de novo synthesized DNA was visualized by autoradiography. (B) Predicted cleavage sites for the
indicated restriction enzymes in human mitochondrial DNA (GenBank AC000021). Asterisk indicates a single nucleotide polymorphism at position
11347, which is found in 3 out of 2704 mtDNA sequences (http://www.genpat.uu.se/mtDB/). (C) DNA was digested for 1h with Xho I (lane 2), Hpa
I (lane 4) or Xho I and Nhe I (lane 5). In (A) and (C), the gel well is indicated as ‘o’. (D) Reactions (in triplicate) for mtDNA synthesis were carried
out using the standard reaction mixture provided with 100mg of HeLa CE in the presence of aphidicolin (100mg/ml, lane 2), ddATP (20 or 100mM,
lanes 3–4) or DMSO (4%, lane 5). De novo synthesized DNA was quantiﬁed using a PhosphorImager. In the control reaction in (lane 1), 100%
indicates the incorporation of 34fmol a-
32P-dATP into full-length mtDNA.
6468 Nucleic Acids Research, 2010,Vol.38, No. 19RESULTS
De novo synthesis of mtDNA in vitro catalyzed by
DNA polymerase c
During eﬀorts to develop an in vitro assay system that
supports replication of human DNA, we found that a
CE fraction supported DNA synthesis in the absence of
an added template (Figure 1A, lane 4). Since DNA was
synthesized by CE without any added template, we sus-
pected that it might be de novo synthesized mtDNA
in vitro. To test this possibility, de novo synthesized
DNA was subjected to restriction enzyme analysis
using Xho I, Hpa I and Nhe I. Digestion of mtDNA
with Xho I should yield a full-length linear fragment of
 16.5kb and Hpa I should generate three DNA frag-
ments, 9.85, 4.3 and 2.4kb in length, as depicted in
Figure 1B. Indeed, Xho I digestion produced a single
DNA fragment (Figure 1C, lane 2) and Hpa I digestion
generated three fragments of the expected size (Figure 1C,
lane 4). In the case of the Xho I/Nhe I double digestion,
we initially predicted the production of two DNA frag-
ments ( 14.2 and 2.4kb) since most human mtDNAs
contain a single cleavage site for each enzyme
(Figure 1B). Unexpectedly, three DNA fragments ( 6.8,
6.2 and 3.6kb) were detected (Figure 1C, lane 5), suggest-
ing the presence of an additional cleavage site. In essence,
these results support that  16kb DNA synthesized in vitro
is mtDNA.
Of a total of 14 human DNA polymerases identiﬁed to
date, three enzymes (pol a, pol d and pol ") take part in
genomic DNA replication and one polymerase (pol g)i s
involved in mtDNA replication (18–21). Pol a, pol d and
pol " are all sensitive to aphidicolin but relatively resistant
to dideoxynucleotides (ddNTPs) such as ddATP (22).
Conversely, pol g is highly sensitive to ddNTPs but resist-
ant to aphidicolin (23). Thus, by determining the sensitiv-
ity of this reaction to aphidicolin and ddNTPs, we
explored whether nuclear or mitochondrial DNA poly-
merases catalyzed the de novo synthesis of the
32P-labeled mtDNA. Simian virus 40 (SV40) DNA repli-
cation was chosen as a control reaction since it requires at
least two replicative DNA polymerases (pol a and pol d)
(24,25). In contrast to SV40 DNA replication, as
summarized in Supplementary Data, mtDNA synthesis
was severely impaired by relatively low levels of ddATP
(20–100mM) (Figure 1D, lanes 3–4) but not by aphidicolin
(100mg/ml) (Figure 1D, lane 2). Taken together, these
results demonstrate that de novo DNA synthesis
observed with CE in the absence of an added DNA
template represents mtDNA synthesis catalyzed by
DNA pol g.
Stable association of de novo synthesized 7S DNA and
mtDNA with mitochondrial factors
As shown in Figure 1A, only full-length mtDNA synthesis
was observed but not 7S DNA synthesis. In those experi-
ments, de novo synthesized DNA was isolated from
reaction mixtures through phenol/chloroform extraction
following treatment with SDS and proteinase K. Since
association of certain mitochondrial factors with
mtDNA is sustained even after SDS and proteinase K
treatment (26–28), we decided to omit the phenol/chloro-
form extraction step in analyzing de novo synthesized
DNA. Instead, reactions were subjected to repeated cen-
trifugations at 10000g. Under this condition, only intact
mitochondria but neither cytoplasmic RNA nor free DNA
could be recovered. After the ﬁnal wash, pelleted sample
as well as supernatant, and total cytoplasmic extract were
analyzed by western blotting. Results show that mitochon-
drial single-stranded DNA-binding protein (mtSSB)
was detected in the total cytoplasmic extract and pellet
(Figure 2A, lanes 1–2) but not in the supernatant
(Figure 2A, lane 3) or nuclear extract (Figure 2A,
lane 4). By contrast, the nuclear protein topoisomerase
IIa was present only in the nuclear fraction (Figure 2A,
lane 4). Throughout the fractionation steps, membrane
detergents were not used, which might explain the
presence of a-tubulin in all fractions (Figure 2A,
lanes 1–4). a-Tubulin is an abundant protein that interacts
with organelle membranes through hydrophobic inter-
actions (29). Detection of mtSSB in the pellet fraction,
but not in the clear cytoplasmic supernatant or NE, dem-
onstrates eﬃcient recovery of mitochondria after repeated
centrifugations.
Next, the pellets enriched in mitochondria were treated
with SDS (0.25%) and proteinase K (0.25mg/ml) in a ﬁnal
volume of 12ml. After incubation for 30min at 37 C, the
lysates were mixed with 3mlo f5   gel loading buﬀer and
directly analyzed on an agarose gel (Figure 2B). Indeed,
omission of phenol/chloroform extraction enabled us to
Figure 2. An optimal reaction condition for 7S DNA synthesis in vitro.
(A) Replication–competent CE (lane 1) was subjected to four consecu-
tive centrifugations at 10000g for 1min. The clear supernatant (lane 3)
obtained after the ﬁrst centrifugation was stored, while the pellet
(lane 2), enriched in mitochondria, was re-suspended in buﬀer G
after four rounds of centrifugation. Subcellular fractions, including
NE (lane 4), were analyzed by western blotting for the indicated
protein with the following aliquots: lane 1, 15mg of CE; lane 2,
4.2mg of mitochondria fraction; lane 3, 15mg of clear CE; lane 4,
10.8mg of NE. (B) A duplicate set of replication reactions was per-
formed in the standard mixture provided with replication–competent
HeLa CE. After 2h incubation, reaction mixtures were subjected to
repeated centrifugations, as described in (A). After the ﬁnal centrifuga-
tion, the pellets were treated with SDS (0.5%) and proteinase K
(0.25mg/ml) in a ﬁnal volume of 12ml. Following 30min incubation
at 37 C, the lysates were directly loaded on an agarose gel, and de novo
synthesized DNAs were resolved by electrophoresis and visualized by
autoradiography. O, the gel well. RI, replication intermediates.
Nucleic Acids Research, 2010,Vol.38, No. 19 6469detect not only de novo synthesized mtDNA but also 7S
DNA (Figure 2B). This result is consistent with reports
that mtDNA and 7S DNA stably associate with mito-
chondrial factors such as mtSSB (27) and ATAd3p (26).
It should be noted that although the quantiﬁcation of
in vitro DNA synthesis was presented only for the
full-length mtDNA and 7S DNA, replication intermedi-
ates, indicated as RI, were estimated to be as much as 25%
of the total dNTP incorporation.
Inﬂuence of nucleotide concentrations on in vitro synthesis
of mtDNA and 7S DNA
With the exception of ATP and GTP, all other nucleotides
required for mtDNA synthesis must be imported from the
cytoplasm or generated through the nucleotide salvage
pathway within mitochondria (30–35). Although nucleo-
tide depletion predictably leads to a decrease in the
mtDNA copy number (32–34,36,37), the impact of the
cytoplasmic nucleotide pool on mtDNA replication has
not been directly investigated. We explored this issue by
measuring synthesis of both mtDNA and 7S DNA using
a-
32P-dATP as tracer in the presence of increasing concen-
trations (0.5–200mM) of dNTP. It should be noted that
though partially adjusted, the speciﬁc radioactivity of
dATP in each reaction generally decreased with higher
dNTP concentrations, as described in the legend of
Figure 3.
One representative set of reactions resolved on an
agarose gel is shown in Figure 3A. Staining with
ethidium bromide (EtBr) revealed no signiﬁcant change
in overall levels of mtDNA and mitochondrial rRNAs
with varying dNTP concentrations. Autoradiography,
however, unveiled diﬀerential changes in mtDNA replica-
tion and 7S DNA synthesis with increasing dNTP concen-
tration (Figure 3B–D). In brief, synthesis of mtDNA
marginally increased, reaching a plateau at 10mMo f
dNTPs (Figure 3C), while 7S DNA synthesis continued
to increase at higher levels of dNTPs (Figure 3C), ac-
counting for as much as 90% of the total observed
DNA synthesis (Figure 3D). This result suggests that 7S
DNA synthesis and mtDNA synthesis may not be coupled
but instead proceed independently in response to varying
nucleotide concentrations. Consistent with this possibility,
our result has also shown that the in vivo level of 7S DNA
relative to mtDNA ﬂuctuates with progression of the cell
cycle (see below).
Figure 3. Inﬂuence of nucleotide concentration on in vitro synthesis of 7S DNA and mtDNA. Replication reactions were performed with HeLa CE
( 1.5 10
5 cell equivalent) in the presence of variable equimolar dNTP levels: lane 1, 0.5mM dNTP/5mCi a-
32P-dATP; lanes 2–4, 2, 5 or 10mM
dNTP/10mCi a-
32P-dATP; lanes 5–7, 20, 50 or 100mM dNTP/20mCi a-
32P-dATP; lane 8, 200mM dNTP/40mCi a-
32P-dATP. For each reaction, the
speciﬁc radioactivity permM dNTP is estimated as follows: lane 1, 2.2 10
7 cpm; lane 2, 1.1 10
7c.p.m.; lane 3, 4.4 10
6c.p.m.; lanes 4–5,
2.2 10
6c.p.m.; lane 6, 8.8 10
5c.p.m.; lanes 7–8, 4.4 10
5c.p.m. After 2h incubation, reaction mixtures were resolved on a 1% agarose gel, as
described in ‘Materials and Methods’ section. Position of mtDNA and two mitochondrial ribosomal DNAs, 16S and 12S rRNA, are indicated in
(A). Immediately after photography, the gel was dried and then subjected to autoradiography to detect newly synthesized 7S DNA, mtDNA and
replication intermediates (RI), as shown in (B). Nucleotide incorporation into mtDNA and 7S DNA was quantiﬁed as described in ’Materials and
methods’ section and average values obtained from four independent experiments are presented in (C). (D) Nucleotide incorporation into 7S DNA is
presented relative to total dNTP incorporation (i.e. 7S DNA + full-length mtDNA).
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in vivo functionality of mitochondria
Next, we asked whether synthesis of mtDNA and 7S DNA
measured in vitro reﬂects the in vivo functionality of
mitochondria. In this study, we utilized HeLa (a cervical
carcinoma line) and U2OS (an osteosarcoma line) cells
since they exhibited marked diﬀerences in their endogen-
ous levels of 7S DNA among all cells tested. First, we
determined the copy number of endogenous mtDNA
and 7S DNA employing real-time quantitative PCR
(RT–qPCR) using a forward primer (primer a) and two
reverse primers (primers b1 and b2) (Figure 4A), as
described in ‘Materials and Methods’ section. The
152bp PCR product was derived from both mtDNA
and 7S DNA, while the 224bp PCR product was
produced only from mtDNA (Figure 4B). Copy
numbers of mtDNA and 7S DNA were determined by
comparing the abundance of PCR product obtained
with mitochondria relative to that with pKW125, a
control plasmid containing the entire mtDNA, as
described previously (17). It was estimated that HeLa
and U2OS cells contained  5100 and 2300 copies of
mtDNA per cell, respectively (Figure 4C). The ratios of
7S DNA to mtDNA in HeLa and U2OS cells were  21.5
and 1.13, respectively (Figure 4D).
We also tested whether the replication capacity of
mitochondria, measured in vitro, reﬂects endogenous
levels of mtDNA and 7S DNA in HeLa and U2OS cells.
When analyzed between 0.5 and 16h of in vitro reaction,
mtDNA synthesis in both HeLa and U2OS mitochondria
increased linearly up to 2h and then slowly plateaued
(Figure 4E–F, open circles). During the ﬁrst 2h of
reaction, the extent of mtDNA synthesis measured with
HeLa CE (Figure 4E, open circles) was signiﬁcantly higher
than that with U2OS CE (Figure 4F, open circles), con-
sistent with their relative levels of endogenous mtDNA
(Figure 4C). A similar pattern was observed for the 7S
DNA synthesis (Figure 4E–F, ﬁlled circles).
Diﬀerential synthesis of mtDNA and 7S DNA with
cell-cycle progression
It is generally believed that mtDNA replication occurs
throughout the cell cycle (38,39). Accordingly, it can be
predicted that the replication capacity of mitochondria
may not signiﬁcantly vary with cell-cycle progression. In
the above, we provided evidence that mtDNA synthesis
measured in vitro using the newly established assay system
reﬂect the in vivo functionality of mitochondria.
Therefore, using the newly established assay system, we
tested how the replication capacity of mitochondria
changes with cell-cycle progression. For this purpose, we
synchronized HeLa cells at diﬀerent stages of the cell cycle
and comparatively determined the replication capacity of
mitochondria and endogenous levels of mtDNA and 7S
Figure 4. Comparative analysis of endogenous levels of mtDNA/7S DNA and the mitochondrial capacity to synthesize mtDNA/7S DNA measured
in vitro.( A) RT–qPCR was performed to measure endogenous levels of mtDNA and 7S DNA using the primer pairs (a+b1) and (a+b2), respectively.
Schematic diagram indicates relative positions of PCR primers and expected PCR products. Numbers on top of mtDNA show nucleotide positions.
(B) An aliquot (5ml) of a representative PCR reaction provided with the primer pair (a+b2) (lane 1) or (a+b1) (lane 2) was analyzed on a 2% agarose
gel and DNA was visualized by EtBr staining. fX174 DNA-Hae III digests, used as a molecular standard, are indicated (M). (C and D) RT–qPCR
was performed with aliquots of diluted CE, equivalent to  300 HeLa cells or  59 U2OS cells. Average copy numbers of mtDNA (C) and 7S DNA
(D) were obtained from two independent duplicate experiments. In (D), numbers on top of each bar indicate fold-abundance of 7S DNA relative to
mtDNA. (E–F) Replication reactions were carried out with aliquots of HeLa CE ( 1.5 10
5 cell equivalents) or U2OS CE ( 5 10
5 cell equiva-
lents). The extent of dNTP incorporation into mtDNA and 7S DNA, obtained from two independent duplicate experiments, is presented.
Nucleic Acids Research, 2010,Vol.38, No. 19 6471DNA. The extent of cell synchronization, measured by
FACS analysis, was estimated to be  95%, as shown in
Figure 5A.
RT–qPCR analysis was performed with aliquots of
mitochondria obtained from synchronous HeLa cells,
which revealed that the ratio of mtDNA to b-actin
genomic DNA remains unchanged during a 4-h transition
from G1/S to S. Considering that b-actin genomic
DNA replicates only in S phase, this result implies that
mtDNA copy number increases in proportion with
genomic DNA content. When cells were released from
the G1/S phase and allowed to progress through S phase
and to reach the next cell-cycle checkpoint, G2/M, by
incubating for an additional 14h in the presence of
nocodazole, mtDNA content increased up to  160%
relative to b-actin (Figure 5B). This result suggests that
in contrast to genomic DNA replicating only in S phase,
mtDNA continuously increased during the 14h transition
from G1/S to G2/M. By simply subtracting the extent of
increase during the ﬁrst 4h in S phase, the mtDNA
content is estimated to increase by additional 60%
during prolonged incubation beyond the ﬁrst 4h of S
phase up until G2/M phase. Overall, this result is consist-
ent with an earlier observation reporting the continuous
mode of mtDNA replication in S phase through G2/M
phase of the cell cycle (38). In contrast to mtDNA,
Figure 5. Comparative analysis of mtDNA replication and 7S DNA synthesis in vivo.( A) Aliquots of HeLa cells ( 1 10
4 cells) synchronized at the
indicated stage of the cell cycle were subjected to FACS analysis. The extent of cell synchrony is presented as percent in parenthesis. (B–D) The copy
number of b-actin gene was determined by RT–qPCR, to which mtDNA copy number was normalized (B). Fold ratio of 7S DNA to mtDNA at
diﬀerent stages of the cell cycle, as determined by qPCR, is presented in (C) where SD and the two-tailed Student’s t-test probabilities of three
independent experiments are shown. (D) Aliquots (5ml) of two representative RT–qPCR reactions provided with the primer pair for mtDNA (lanes
1–2), b-actin gene (lanes 3–4), or 7S DNA (lanes 5–6), were analyzed on a 2% agarose gel. (E) The mitochondrial capacity to synthesize mtDNA and
7S DNA was determined with aliquots (5ml) of replication competent CE prepared from HeLa cells synchronized at the indicated stage of the cell
cycle. After 2h or 14h incubation, reaction mixtures were resolved on a 1% agarose gel. Positions of mtDNA and 7S DNA are indicated.
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with cell-cycle progression. The ratio of 7S DNA to
mtDNA increased almost 7-fold when cells entered into
S phase from the G1/S boundary (Figure 5C). Aliquots
(5ml) of the two representative reactions were subjected to
agarose gel electrophoresis, which conﬁrmed that expect-
edly, RT–qPCR reactions yielded amplicons of 224bp
from mtDNA (Figure 5D, lanes 1–2), 256bp from
b-actin gene (Figure 5D, lanes 3–4), and 152bp from
both 7S DNA and mtDNA (Figure 5D, lanes 5–6).
We asked whether the changes in endogenous levels of
mtDNA and 7S DNA reﬂect the varying functionality of
mitochondria along the cell cycle. Our study, performed
with heterogeneous HeLa CE prepared from an exponen-
tially growing population, revealed that during the transi-
tion from 2 to 14h incubation newly synthesized mtDNA
and 7S DNA increased about 1.4- and 2.6-fold, respect-
ively (Figure 4E). Taking this observation into consider-
ation, we compared the replication capacity of
mitochondria in HeLa cells synchronized at diﬀerent
stages of the cell cycle by determining the fold-change in
mtDNA and 7S DNA newly synthesized in vitro during
the transition from 2 to 14h incubation. Regardless of the
cell cycle, newly synthesized mtDNA increased about 1.3-
to 1.4-fold (Figure 5E), reminiscent of the result shown in
Figure 4E. This result suggests that the mitochondrial
capacity to synthesize mtDNA remains relatively un-
changed throughout the cell cycle. However, it should be
noted that a signiﬁcant fraction of newly synthesized
mtDNA in S phase mitochondria exhibits a diﬀerent mi-
gration pattern (lanes 3–4). Therefore, unlike the capacity
to synthesize mtDNA, mitochondria might undergo as yet
unknown functional changes in S phase to catalyze a
faster introduction of negative superhelicity into newly
synthesized mtDNA. Changes in mitochondrial function-
ality along the cell cycle can be clearly seen from its
capacity to synthesize 7S DNA that signiﬁcantly ﬂuctuates
with cell-cycle progression: newly synthesized 7S DNA
increased about 1.8-, 7.8- and 2.5-fold in mitochondria
at G1/S, S and G2/M phase, respectively (Figure 5E).
This result well reﬂects endogenous levels of mtDNA
and 7S DNA measured by RT–qPCR (Figure 5C). Thus
we conclude that mitochondrial functionality to synthesize
7S DNA but not mtDNA changes along the cell cycle.
DISCUSSION
In this report, we describe an in vitro assay system with
which both mtDNA and 7S DNA are synthesized in vitro
in such a way to reﬂect the in vivo replication capacity of
mitochondria. Also, we provide experimental evidence for
the ﬁrst time that the replication capacity of mitochondria
correlates with the endogenous copy number of both
mtDNA and 7S DNA and that 7S DNA synthesis
highly ﬂuctuates with cell-cycle progression, whereas
mtDNA synthesis occurs throughout the cell cycle.
Consistently, our study illustrates that 7S DNA synthesis
is highly inﬂuenced by varying nucleotide concentrations.
Prior to our observation, there have been several reports
on in vitro synthesis of mtDNA (11–15,40). In 1991, Jui
and Wong (13) reported for the ﬁrst time in vitro synthesis
of mtDNA using HeLa mitochondria permeabilized with
Triton X-100. In their study, the use of the TCA precipi-
tation method led them to score  4–5pmol of TTP in-
corporation into acid-insoluble DNA polymer for 1h in
a reaction (100ml) provided with permeabilized
mitochondria (300mg). However, when DNA was
isolated from the reaction mixture by phenol/chloroform
extraction followed by ethanol precipitation and subse-
quently resolved on an agarose gel, only heterogeneous
DNAs were detected (13). In 1994, Enriquez et al. (11)
reported that an in vitro assay system was established for
highly eﬃcient mtDNA synthesis using mitochondria
isolated from rat liver. However, from a reaction
(0.5ml) provided with relatively high levels of
mitochondria (1mg), only <2fmol dNTP was
incorporated into full-length mtDNA for 2h under the
optimal condition (11). More recently, using essentially
the same assay system, Wiesner and colleagues reported
that 7S synthesis was enhanced when exogenous TFAM
was imported into rat mitochondria permeabilized with
Triton X-100 (1%) (12). However, de novo synthesized
7S DNA was not quantiﬁed and full-length mtDNA rep-
lication was not detected. These somewhat variable obser-
vations on mtDNA replication and 7S DNA synthesis
may be due to a poor synthesis of both mtDNA and 7S
DNA in the presence of Triton X-100 (data not shown)
and also a poor recovery of both mtDNA and 7S DNA
after phenol/chloroform extraction. By contrast, the
in vitro assay system described in this study allowed
us to detect both full-length mtDNA and 7S DNA with
relatively higher eﬃciency:  34fmol dATP was
incorporated into full-length mtDNA during 2h incuba-
tion in a reaction (20ml) provided with  100mg HeLa CE
(Figure 1D, lane 1).
Reactions for SV40 DNA replication (Supplementary
Data) was provided with 0.5mg of the template pSVLD
(10kb), which is equivalent to  2.3 10
11 molecules of
the template DNA. Incorporation of 143fmol dATP
into SV40 DNA equals production of  1.7 10
7
daughter molecules; one copy per every 13530 template
DNA. In case of mtDNA replication (Supplementary
Figure S1D, lane 1), considering the size (16569bp) of
mtDNA and its endogenous copy number (5100/cell)
(Figure 4C), incorporation of 34fmol dATP corresponds
to production of  2.5 10
6 molecules of full-length
mtDNA on  7.7 10
8 molecules of endogenous
template. Although the mtDNA synthesis observed
in vitro was only  0.3% of the input template (one copy
per every 308 molecules of template DNA), mtDNA syn-
thesis in vitro can be considered fairly eﬃcient as
compared to in vitro SV40 DNA replication.
Our results showing that endogenous levels of mtDNA
and 7S DNA do not correlate to each other, nor the extent
of their synthesis, appears to be at odds when considering
the following observations that implicate 7S DNA in
mtDNA replication. (i) The 7S DNA is present in the
D-loop region where de novo H-strand synthesis initiates
(41–43). (ii) The 50-end of 7S DNA coincides with the OH
(10). (iii) The 7S DNA possesses a 30-OH end that can be
extended by DNA polymerase b in vitro (40), suggesting
Nucleic Acids Research, 2010,Vol.38, No. 19 6473that 7S DNA has a potential to serve as a primer for the
synthesis of full-length mitochondrial DNA. (iv) In
addition, it is possible that through the formation or
maintenance of the D-loop, the 7S DNA may facilitate
the replication complex to assemble on the OH.
Although the presence of 7S DNA in the D-loop region
can be a hallmark of replicating mitochondrial DNA, all
of the above observations, implicating 7S DNA in
mtDNA replication, have yet to be experimentally
veriﬁed. In addition, although the proposed functions
for 7S DNA presuppose its physical association with
mtDNA how and when 7S DNA associates with
mtDNA remains poorly understood. An earlier study by
Clayton and colleagues made an intriguing observation
that a large fraction of newly synthesized 7S DNA is
associated with non-replicating mitochondrial DNA
(44). In a subsequent study, they found that  20% of
mitochondrial nucleotides are utilized for the synthesis
of 7S DNA but over 95% of newly synthesized 7S DNA
are rapidly lost with an estimated half-life of 70min (45).
Based on the high turnover rate of 7S DNA in isolated rat
mitochondria, Gensler and colleagues argued that 7S
DNA is not an intermediate of leading strand synthesis
during replication (12). In support of this view, Attardi
and coworkers reported that diﬀerent replication origins
are utilized for the synthesis of 7S DNA and the H-strand
of full-length mtDNA (46). They proposed that
mitochondria harbor two types of mtDNA replications,
one for mtDNA maintenance under steady-state condi-
tions and another for accelerating mtDNA replication in
response to certain physiological demands such as
recovery after mtDNA depletion. In the proposed
model, they reasoned the involvement of 7S DNA in the
latter (46). Although this is an attractive possibility, the
function of 7S DNA under normal physiological condi-
tions remains largely unknown.
While nuclear DNA replication takes place only in S
phase of the cell cycle, mtDNA replication is believed to
occur throughout the cell cycle (38,39,47,48). Unlike the
nucleus where nucleotides are rapidly depleted upon com-
pletion of DNA replication (39), mitochondria may have
evolved to maintain their own nucleotide pool to support
mtDNA replication throughout the cell cycle. In support
of this possibility, Bogenhagen and Clayton (30) reported
that treatment of mouse LMTK
  cells with methotrexate,
an inhibitor of de novo nucleotide synthesis, inhibited over
96% of nuclear DNA synthesis but under the same con-
dition, mtDNA synthesis continued at 50–60% of the
control level for at least 10h. In this regard, the present
study may suggest a novel regulatory pathway for
mtDNA synthesis, which consists of 7S DNA synthesis
and its degradation. In brief, we show that 7S DNA syn-
thesis is highly stimulated in S phase when nucleotide de
novo synthesis actively takes place. Considering the rela-
tively short half-life of 7S DNA (<70min) (12,44,45), it is
plausible that the mitochondrial nucleotide pool can be
signiﬁcantly inﬂuenced by degradation of 7S DNA
relative to its synthesis, particularly outside of S phase
when the dNTP supply is limited. Since mitochondria
are well equipped with salvage enzymes such as TK2
and dGK (34,49), free dNMP, generated through 7S
DNA degradation, could be converted to dNTP, and sub-
sequently utilized for mtDNA replication.
In non-dividing cells that lack de novo synthesis of nu-
cleotides, the salvage enzymes are expected to play key
roles in the maintenance of both the nuclear genome
and mtDNA, by providing necessary nucleotides under
dynamically changing nutrient conditions. It would be
very informative to determine how endogenous levels of
7S DNA and the extent of 7S DNA synthesis relative to
mtDNA replication ﬂuctuate under diverse growth and
diﬀerentiation conditions. This would help establish
whether 7S DNA synthesis and degradation aﬀect
mtDNA replication and the maintenance of the mitochon-
drial genome. Such studies will be greatly facilitated if
cellular factors are identiﬁed that inﬂuence 7S DNA syn-
thesis/degradation. Those factors could function in con-
junction with replication factors and/or modulate the
degradation of 7S DNA. Existence of such factors has
been reported in a recent study, led by I. Holt (50),
which describes that POLGb, the accessory subunit of
pol g, positively regulates the 7S DNA level relative to
mtDNA.
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Supplementary Data are available at NAR Online.
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